Could a stroke pill boost brainpower in elderly epilepsy patients?
NCT ID NCT07193277
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether butylphthalide, a drug already used for stroke in China, can improve cognitive function in 220 elderly patients (ages 60-85) who have both focal epilepsy and mild cognitive impairment. Participants take the drug or a placebo for 48 weeks while continuing their usual seizure medication. The main goal is to see if thinking and memory scores improve, addressing a common problem that current epilepsy treatments don't help.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
butylphthalide (a neuroprotective drug currently approved in China for acute ischemic stroke)
What this could lead to
If it works, this could point toward a treatment for cognitive decline in elderly people with epilepsy, filling a gap where current epilepsy drugs only control seizures.
What could go wrong
This is a Phase 4 trial with 220 participants, so results are still uncertain. Butylphthalide is not yet approved for this use, and the cognitive benefits seen in other conditions may not apply here. Side effects are possible, though the drug is generally well-tolerated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, Zhejiang, 325000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••